• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮及其他自身免疫性疾病中的I型干扰素

Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

作者信息

Banchereau Jacques, Pascual Virginia

机构信息

Baylor Institute for Immmunology Research, 3434 Live Oak, Dallas, Texas 75204, USA.

出版信息

Immunity. 2006 Sep;25(3):383-92. doi: 10.1016/j.immuni.2006.08.010.

DOI:10.1016/j.immuni.2006.08.010
PMID:16979570
Abstract

Different genetic alterations may lead to type I interferon (IFN) overproduction in human systemic lupus erythematosus (SLE). The increased bioavailability of type I IFN contributes to peripheral tolerance breakdown through the activation of immature myeloid dendritic cells (mDCs). IFN-matured mDCs activate autoreactive T cells. These cells, together with plasmacytoid DCs, help expand autoreactive B cells. IFN-matured DCs also activate cytotoxic CD8+ T cells, possibly increasing apoptotic cell availability. The capture of apoptotic cells by mDCs and of nucleic acid-containing immune complexes by plasmacytoid DCs and B cells amplifies the autoimmune reaction leading to disease manifestations. Genetic alterations in lineages other than B cells might explain other autoimmune syndromes where type I IFNs appear to be involved.

摘要

不同的基因改变可能导致人类系统性红斑狼疮(SLE)中I型干扰素(IFN)的过度产生。I型干扰素生物利用度的增加通过激活未成熟髓样树突状细胞(mDC)导致外周耐受破坏。IFN成熟的mDC激活自身反应性T细胞。这些细胞与浆细胞样DC一起,有助于扩增自身反应性B细胞。IFN成熟的DC还激活细胞毒性CD8+T细胞,可能增加凋亡细胞的可用性。mDC对凋亡细胞的捕获以及浆细胞样DC和B细胞对含核酸免疫复合物的捕获会放大自身免疫反应,导致疾病表现。B细胞以外谱系的基因改变可能解释其他似乎涉及I型干扰素的自身免疫综合征。

相似文献

1
Type I interferon in systemic lupus erythematosus and other autoimmune diseases.系统性红斑狼疮及其他自身免疫性疾病中的I型干扰素
Immunity. 2006 Sep;25(3):383-92. doi: 10.1016/j.immuni.2006.08.010.
2
A compass that points to lupus: genetic studies on type I interferon pathway.指向狼疮的指南针:I型干扰素通路的遗传学研究
Genes Immun. 2007 Sep;8(6):445-55. doi: 10.1038/sj.gene.6364409. Epub 2007 Jun 21.
3
Systemic lupus erythematosus: all roads lead to type I interferons.系统性红斑狼疮:条条大路通I型干扰素。
Curr Opin Immunol. 2006 Dec;18(6):676-82. doi: 10.1016/j.coi.2006.09.014. Epub 2006 Oct 2.
4
Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression.系统性红斑狼疮患者循环中的浆细胞样树突状细胞数量增加,但髓样树突状细胞数量减少且CD83表达不足。
Lupus. 2008 Jul;17(7):654-62. doi: 10.1177/0961203308089410.
5
Type-I interferons and systemic lupus erythematosus.I 型干扰素与系统性红斑狼疮
Autoimmun Rev. 2006 Oct;5(8):554-62. doi: 10.1016/j.autrev.2006.05.002. Epub 2006 Jun 27.
6
Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.坏死或晚期凋亡细胞释放的含核酸免疫复合物及狼疮IgG诱导浆细胞样树突状细胞产生α干扰素
Arthritis Rheum. 2004 Jun;50(6):1861-72. doi: 10.1002/art.20254.
7
Dendritic cells and interferon-mediated autoimmunity.树突状细胞与干扰素介导的自身免疫
Biochimie. 2007 Jun-Jul;89(6-7):856-71. doi: 10.1016/j.biochi.2007.04.013. Epub 2007 May 5.
8
A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.浆细胞样树突状细胞-Ⅰ型干扰素轴在系统性红斑狼疮发病机制中起关键作用。
Int J Mol Sci. 2015 Jun 23;16(6):14158-70. doi: 10.3390/ijms160614158.
9
Lupus-like disease and high interferon levels corresponding to trisomy of the type I interferon cluster on chromosome 9p.狼疮样疾病以及与9号染色体短臂上I型干扰素基因簇三体性相对应的高干扰素水平。
Arthritis Rheum. 2006 May;54(5):1573-9. doi: 10.1002/art.21800.
10
Plasmacytoid dendritic cells and interferon-alpha in Aicardi-Goutières syndrome.
Neuropediatrics. 2007 Dec;38(6):269-75. doi: 10.1055/s-2008-1065352.

引用本文的文献

1
E3 ligase RAD18 targets phosphorylated IRF3 to terminate IFNB1 transcription.E3泛素连接酶RAD18靶向磷酸化的IRF3以终止IFNB1转录。
Nat Immunol. 2025 Sep;26(9):1581-1595. doi: 10.1038/s41590-025-02256-x. Epub 2025 Aug 29.
2
The ubiquitin E3 ligase TRIM21 suppresses type I interferon signaling via STING degradation and ameliorates systemic autoimmunity.泛素E3连接酶TRIM21通过STING降解抑制I型干扰素信号传导并改善全身性自身免疫。
Exp Mol Med. 2025 Jul 3. doi: 10.1038/s12276-025-01490-5.
3
Cellular and molecular determinants mediating the dysregulated germinal center immune dynamics in systemic lupus erythematosus.
介导系统性红斑狼疮中失调的生发中心免疫动力学的细胞和分子决定因素。
Front Immunol. 2025 Feb 13;16:1530327. doi: 10.3389/fimmu.2025.1530327. eCollection 2025.
4
Explainable deep neural networks for predicting sample phenotypes from single-cell transcriptomics.用于从单细胞转录组学预测样本表型的可解释深度神经网络。
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbae673.
5
CAR-based cell therapies for systemic lupus erythematosus.用于系统性红斑狼疮的基于嵌合抗原受体的细胞疗法。
Chin Med J (Engl). 2024 Dec 17;138(5):523-30. doi: 10.1097/CM9.0000000000003406.
6
Modulation of antigen delivery and lymph node activation in nonhuman primates by saponin adjuvant saponin/monophosphoryl lipid A nanoparticle.皂苷佐剂皂苷/单磷酰脂质A纳米颗粒对非人灵长类动物抗原递送和淋巴结激活的调节作用。
PNAS Nexus. 2024 Nov 25;3(12):pgae529. doi: 10.1093/pnasnexus/pgae529. eCollection 2024 Dec.
7
Revisiting the heterogeneity of interferon-related autoimmune diseases.重新审视干扰素相关自身免疫性疾病的异质性。
Nat Rev Rheumatol. 2025 Jan;21(1):7-8. doi: 10.1038/s41584-024-01196-4.
8
Comparison of cell type and disease subset chromatin modifications in SLE.比较 SLE 中细胞类型和疾病亚群的染色质修饰。
Clin Epigenetics. 2024 Nov 14;16(1):159. doi: 10.1186/s13148-024-01754-3.
9
Therapeutically targeting proinflammatory type I interferons in systemic lupus erythematosus: efficacy and insufficiency with a specific focus on lupus nephritis.靶向治疗系统性红斑狼疮中的促炎型 I 型干扰素:疗效和不足,特别关注狼疮肾炎。
Front Immunol. 2024 Oct 16;15:1489205. doi: 10.3389/fimmu.2024.1489205. eCollection 2024.
10
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments.解读成人红皮病的病因:临床表现、诊断工具、病理生理学和治疗方法的最新指南。
Am J Clin Dermatol. 2024 Nov;25(6):927-950. doi: 10.1007/s40257-024-00886-9. Epub 2024 Sep 30.